Date: Saturday, February 14
Time: 10:30am-12:30pm
Location: Berkeley Methodist United Church
Registration is required.
Description
Psilocybin, one of the hallucinogenic compounds found in “magic mushrooms” has shown early promise in treating depression and anxiety that has especially proved resistant to conventional antidepressants. A recent pilot study led by Dr. Ellen Bradley at UCSF found early evidence that psilocybin therapy has a strong safety profile for people with early to moderate Parkinson’s disease and that it may improve mood, cognition, and possibly motor symptoms. In this talk, Dr. Bradley will share some of the salient findings from that study and ongoing efforts to advance the research around psychedelic drugs to benefit the PD community.
Find out more about the study.
Bio
Ellen Bradley, MD is an assistant professor of psychiatry and behavioral sciences at UCSF, and lead psychiatrist for the Parkinson’s Disease Research, Education, and Clinical Center at the San Francisco VA Medical Center. Her work focuses on advancing multidisciplinary care for people living with Parkinson’s disease and related neuropsychiatric conditions. Through clinical trials, she researches how psychoactive compounds affect brain function and their potential to support treatment for Parkinson’s disease and related conditions.
Contact us at operations@pdactive.org or (510) 479-6119 if you need assistance registering.
PD Active depends on donations to bring programs like this to our members free of charge. We remain grateful for your contributions.